Literature DB >> 16362600

Hemodynamic effects of sildenafil citrate (Viagra) on segmental branches of bilateral renal arteries.

Arslan Ardicoglu1, Ercan Kocakoc, Veysel Yuzgec, Zulkif Bozgeyik, Halit Canatan, Adem Kiris.   

Abstract

INTRODUCTION: Erectile dysfunction (ED) is one of the most encountered male health problem and sildenafil citrate is used worldwide for treatment of ED. Aim of the present study was to determine and evaluate hemodynamic effects of sildenafil citrate on segmental branches of bilateral renal arteries of cases with ED. PATIENTS AND METHODS: Total of 35 male patients aging between 34 and 56 years were recruited into study. Patients were evaluated with renal color Doppler sonography (CDS) before and after (45-75 min) peroral sildenafil citrate (50 mg) administration. Peak systolic flow rate (V(max)), end diastolic flow rate (V(min)), resistive index (RI) and pulsatility index (PI) of renal artery segmental branches were determined before and after sildenafil citrate administration.
RESULTS: V(min) measured at right lower segment was significantly reduced after sildenafil administration (p = 0.030). Accordingly mean RI and PI of right lower segment of renal artery slightly increased after drug administration (p = 0.007 and p = 0.012, respectively). The measurements on other segments had no significant change after sildenafil treatment when compared to baseline values. On this single dose administration no side effect was recorded.
CONCLUSION: Findings of the present study demonstrated that peroral sildenafil citrate usage had slight effects on hemodynamic parameters of lower segmental branch of right renal artery. This result could not be interpreted as robust evidence for hemodynamic changes of renal arteries associated with sildenafil usage nevertheless warrants more comprehensive research with larger number of patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362600     DOI: 10.1007/s11255-005-3621-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  29 in total

1.  Hemodynamic effects of sildenafil in men with severe coronary artery disease.

Authors:  H C Herrmann; G Chang; B D Klugherz; P D Mahoney
Journal:  N Engl J Med       Date:  2000-06-01       Impact factor: 91.245

Review 2.  Evaluation and treatment of erectile dysfunction in men with diabetes mellitus.

Authors:  Jayant Dey; Mark Devin Shepherd
Journal:  Mayo Clin Proc       Date:  2002-03       Impact factor: 7.616

3.  Intracavernous injection of papaverine for erectile failure.

Authors:  R Virag
Journal:  Lancet       Date:  1982-10-23       Impact factor: 79.321

Review 4.  NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence.

Authors: 
Journal:  JAMA       Date:  1993-07-07       Impact factor: 56.272

5.  Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis.

Authors:  S Türk; G Karalezli; H Z Tonbul; M Yildiz; L Altintepe; A Yildiz; M Yeksan
Journal:  Nephrol Dial Transplant       Date:  2001-09       Impact factor: 5.992

6.  Effects of sildenafil citrate (viagra) on blood pressure in normotensive and hypertensive men.

Authors:  Yoram Vardi; Lavi Klein; Suliman Nassar; Elliot Sprecher; Ilan Gruenwald
Journal:  Urology       Date:  2002-05       Impact factor: 2.649

7.  Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro.

Authors:  R M Wallis; J D Corbin; S H Francis; P Ellis
Journal:  Am J Cardiol       Date:  1999-03-04       Impact factor: 2.778

8.  Sildenafil-associated nonarteritic anterior ischemic optic neuropathy.

Authors:  Howard D Pomeranz; Kyle H Smith; William M Hart; Robert A Egan
Journal:  Ophthalmology       Date:  2002-03       Impact factor: 12.079

9.  Tolerability and safety profile of sildenafil citrate (Viagra) in Latin American patient populations.

Authors:  O R Coelho
Journal:  Int J Impot Res       Date:  2002-08       Impact factor: 2.896

10.  Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive men.

Authors:  A Mahmud; M Hennessy; J Feely
Journal:  J Hum Hypertens       Date:  2001-10       Impact factor: 3.012

View more
  1 in total

Review 1.  Phosphodiesterase type 5 inhibitors and kidney disease.

Authors:  Baris Afsar; Alberto Ortiz; Adrian Covic; Abduzhappar Gaipov; Tarik Esen; David Goldsmith; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2015-08-05       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.